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Abstract 
Objective: To perform a clinical and histological evaluation, characterizing and proving the 
feasibility of the use of beta tricalcium phosphate (HA/βTCP) bioceramics as a bone defect repair 
material, comparing it with autogenous bone and blood clot in terms of osteoinductive, 
conductive, and genic capacities. Material and Methods: The experiment was based on 3 critical 
defects in the mandible of 11 New Zealand rabbits. The defects were filled with HA/βTCP 
bioceramics and autogenous bone, respectively, collected and ground during the development of 
defects and blood clots. The animals were euthanized after the 90-day experiment and samples 
were collected for histomorphological examination. To evaluate differences between the groups, 
a one-way analysis of variance (ANOVA) was performed with Tukey’s post hoc test. An α value 
lower than 0.05 was considered statistically significant. Results: Microscopy revealed the 
presence of osteoblasts, osteoclasts, and osteocytes associated or not associated with the presence 
of mature or immature bone. All the studied materials presented bone neoformation in all cases, 
with the presence of mature and immature bone. Regarding the presence of HA/βTCP 
bioceramic residual material, the same was found in 7 of 11 slides. Conclusion: HA/βTCP 
bioceramics were shown to be a biocompatible bone substitute, with osteoinductive and 
osteoconductive characteristics, accelerating the process of new bone formation when compared 
with autogenous and blood clotted bone, thereby showing promise for bone defect repair with 
safety and efficacy. 
 
Keywords: Dental Implants; Bone and Bones; Hydroxyapatites; Ceramics.
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Introduction 
Recently, much effort has been made to find solutions to correct bone defects for placing 
osteointegration implants. Biomaterials are remarkable in this regard, as they eliminate the need to 
remove autogenous bone. One of the referred biomaterials, highlighted in the present study, is beta 
tricalcium phosphate (βTCP) bioceramics associated with hydroxyapatite. 
It has been demonstrated that βTCP bioceramics is a material with properties that can 
promote osteoinduction, i.e., the capacity to store proteins and cells that are viable, specific, and 
particular to the individual receiving the implant; thus, allowing natural bone neo-formation and 
biocompatibility, with problems restricted to its accelerated absorption [1,2]. 
Synthetic hydroxyapatites (HA), despite having a different composition and morphology, 
resemble natural bone the most, and are, therefore, an option for cases in which it is necessary to 
recover lost bone structure and fill in defects, because of its high osteogenic potential and structural 
maintenance with slow resorption [2,3]. 
 To analyze alveolar repair using biomaterials, a study filled in the alveoli using an average 
0.78 g of βTCP bioceramics without membranes. One first subjective visual clinical analysis rated it 
as very good to good for 87% of the cases post grafting. Radiographic analysis after 12 months 
revealed the presence of βTCP bioceramics granules in 30% of the cases, as well as reabsorption in 
height and width in 10% of the cases. The effectiveness of the treatment was rated as good and very 
good in 89% of the cases. For 100% of the cases there was no reactions or complications regarding 
the material. Clinically, it was observed that cases that used membranes were superior. It was 
concluded that the technique using membranes and βTCP bioceramics is recommended for the 
maximum preservation of alveoli for further implant prosthetic rehabilitation [4]. 
Another study performed a histological and histomorphometric analysis of autogenous bone 
versus βTCP bioceramics alone in 20 cases of bilateral sinus lift. On one side, βTCP bioceramics 
alone were placed, and on the other autogenous bone, in each patient. It was found no significant 
difference in the histologic and histomorphometric analyses in the experimental and control groups 
after 6 months; thus, being considered a good material for this type of treatment [5]. 
Studies have demonstrated mandibular reconstructions with βTCP bioceramics associated 
with autogenous bone in a proportion of 30% to 50% depending on the case. A total of 152 patients 
with various defects such as: bone repair after cystic exeresis, alveolar reconstruction, maxillary 
sinus lift, fractures of alveolar fractures, periodontal regeneration, reconstruction after removal of 
tumors and apicectomies, all defects being > 2 cm, were analyzed. The βTCP bioceramics in particles 
of 500-2,000 µm and post-operative control of 4, 12, and 52 weeks were used. The authors reported 
easy application of the material; in 9.2% of the cases there was local irritation with granule loss; in 
2% of the cases there was total loss of the material; and in 88.8% of the cases there was complete 
reabsorption of the material with simultaneous bone replacement, observed radiographically and 
histomorphometrically. It was also reported that the insertion of dental implants in the grafted 
region could be performed 5-6 months after the graft [6,7]. 
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Another study reported the use of composites of HA + carbon and HA + carbon + sodium 
bicarbonate, in bone defects in rabbit ulnas. The evidence of early bone regeneration, absence of 
infection, rejection, efficiency, and high reliability of the materials could be seen [8]. 
Researchers have reported studies of maxillary sinus lift with βTCP. For this purpose, 17 
bilateral edentulous patients had βTCP bioceramics grafted on one side and autogenous bone was 
used on the other. After 6 months, 68 implants were placed, and bone removed from the site was 
histomorphometrically analyzed. The bone density showed no significant difference between the 
sides, but the biodegradation was significantly slower on the βTCP bioceramic side, whereas the 
bone trabeculation pattern on the β-TCCP side was lower than that of the autogenous bone, but 
without significant differences. It was concluded that after 6 months, implants could be anchored 
without major problems in grafting with βTCP bioceramics [9,10]. 
The performance of the resorbable bioceramics was evaluated using tricalcium phosphate 
silicon as a stabilizer in the repair of extensive defects in the long bones of sheep. The evaluation was 
performed through sequential radiographs, tomography, histology, immunohistology, and 
microradiography to analyze the density and percentage of bone growth. They concluded that there 
was excellent integration and significant bone regeneration besides evident osteoclastic biomaterial 
reabsorption. At the end of the first year the remainder of the biomaterial was 10-20% and after the 
second year it was completely reabsorbed, with the defect completely filled by new, highly 
mineralized, lamellar bone [11]. 
In an animal study carried out with 8 rabbits, βTCP bioceramic blocks and βTCP bioceramic 
blocks treated with PRP for onlay growth were compared. It was concluded after 3 months that 
there was no inflammatory process in any of the blocks, and the association with PRP did not result 
in any significant improvement in bone growth [12,13].  
Therefore, animal studies are of paramount importance for the timely and safe comparison of 
biomaterials of varied characteristics, with control groups, such as autogenous bone and blood clot, 
and for treatments, if they were tested in human patients, avoiding, in this way, suffering and 
damage to humans [14]. 
The objective of this study was to perform a clinical and histological evaluation, 
characterizing and proving the feasibility of the use of HA/βTCP bioceramics as a bone defect repair 
material, comparing it with autogenous bone and blood clot in terms of osteoinductive, conductive, 
and genic capacities. 
 
Material and Methods 
The rabbits used in this study were obtained from the Santo Amaro University (UNISA) 
Animal Facility, and were monitored and medicated by the veterinarian team of the facility. All 
surgical procedures were performed at the UNISA Multidisciplinary Laboratory of Veterinary 
Surgery Techniques, and the rabbits had undergone 12 hours absolute fasting as per veterinary 
instruction and supervision. 
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Eleven female New Zealand rabbits were selected for the experimental surgical procedures, 
with ages ranging between 4 and 6 months, and weights between 3.0 and 3.5 kg. The animals were 
weighed and on the day of the procedure the selected animals received pre-anesthetic medication 
(intramuscular), consisting of 0.2 ml Acepran 1%. In every procedure, the animals were anesthetized 
using an association (intramuscular) of Cetamin (40 mg/kg), Xylazin (5 mg/kg), and Meperidine (10 
mg/kg), and were monitored by the responsible veterinary team, receiving further half-dose 
applications according to their need during the procedure [11]. 
The area was shaved and antisepsis was performed with povidone-iodine followed by 
infiltrative local anesthesia with Mepivacaine 2% without vasoconstrictor. Two separate bilateral 
rectilinear incisions were made in the antero-posterior mandible of the rabbits, according to the 
anatomy verified through palpation, using scalpel number 15. A patch was then removed to expose 
the bone tissue of the mandible, using periosteum lifters. In every procedure, a veterinarian of the 
same team monitored the heart rate, respiration, and palpebral reflexes of the animals. 
Next, three inlay bony defects were made mechanically on the mandible of the rabbits, using 
a straight surgical instrument, electric motor, and trephines, under constant irrigation using 
physiological saline (0.9%). The defects were 7 mm in diameter and 3 mm deep; two were made on 
the left side of the mandible and one on the right (Figure 1). 
 
   
 A 
 
 B 
   
C 
 
 
D 
Figure 1. A: Defects; B: Defects empty; C: Autogenous bone/βTCP blood; D: Blood clot. 
 
To facilitate posterior identification and standardization of the defects, the animal’s teeth 
were used as reference. On the left side, the anterior defect was made in the direction of the second 
posterior tooth, and the posterior defect was made after the last posterior tooth. On the right side, 
the defect was made in the direction between the third and fourth posterior teeth. All defects were 
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made 4 mm above the mandibular ridge. After making the defects, we carefully marked the external 
cortical of the mandible in the region of the defects and stored this cortical bone with physiological 
saline at 0.9% for further use [12]. 
The defects were filled in as follows: the first, on the right mandible side with a blood clot 
(control group); the second, on the anterior left side with autogenous bone removed when the defects 
were trephined and crushed using a bone grinder; and the third, on the left posterior side with 
HA/βTCP bioceramics, always respecting a distance of at least 3 mm between the 2 defects. After 
filling in the defects, the full patch was repositioned and the tissues were sutured with simple stitches 
by using nylon 3.0. 
The rabbits were kept for 7 days in individual cages, which were cleaned daily, and then 
moved to cells that housed three animals, thus allowing minor motility and reducing stress during 
the observation period. The environment was maintained under controlled temperature and 
luminosity, and the animals were fed 3 times a day with Nutriara® ration (Nutriara Alimentos Ltd., 
Cuiabá, MT, Brazil) and had water ad libitum. The animals received subcutaneous postoperative 
medication for 7 days: Enrofloxacin (5 mg/kg) and Flunixin Meglumine (1.1 mg/kg) [11]. 
The rabbits were sacrificed after 12 weeks, by using a technique recommended by Brazilian 
College of Animal Experimentation, consisting of an overdose of general anesthetic (Thiopentax®) 
associated with an intravenous injection of potassium chloride (19.1%). The assessment time was 
standardized as 3 months, as this period corresponded to approximately 9 months in humans. This 
time interval used for the assessment was justified by previous studies that showed the bone 
metabolism in rabbits is approximately 3 times faster than that in humans, and could be used as the 
foundation for research with an allometric scale [11,13,14]. 
Next, material was removed from the respective location with 7-mm diameter trephines. A 
clinical analysis was performed and any changes in the defects were registered. The specimens were 
stored in formaldehyde at 10%, stained with hematoxylin and eosin (HE) by histology technicians, 
and forwarded to the pathologic anatomy laboratory to prepare the histologic blades. 
The blades were photographed and digitalized (micrography) and then analyzed (Plínio S 
Anatomia Patológica S/C Ltda, São Paulo, SPB, Brazil) for the presence of cells suitable for bone 
maturation, such as osteoblasts, osteoclasts, osteocytes, and evidence of material waste. 
 
Data Analysis 
Mean values and standard deviations were obtained. Data were analyzed using IBM SPSS 
Statistics for Windows Software, version 18 (IBM Corp., Armonk, NY, USA). To evaluate 
differences between the sample and control, a one-way analysis of variance (ANOVA) was performed 
with Tukey’s post hoc test. An α value lower than 0.05 was considered statistically significant. 
 
Ethical Aspects 
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The research was approved by the Research Ethics Committee of Santo Amaro University 
(Protocol No. 011/2008). It was carried out in accordance with the ethical principles of animal 
experimentation elaborated by the Brazilian College of Animal Experimentation (COBEA), affiliated 
to the International Council of Laboratory Animal Science (ICLAS). 
 
Results 
The results were analyzed considering the clinical evolution of the animals, as well as the 
healing process of the bone neo-formation of the defects made on the animal’s mandibles. Regarding 
the immediate postoperative clinical aspects, after post-anesthetic recovery, all animals were healthy 
and all local masticatory and sensorial functions were preserved (Table 1). 
 
Table 1. Representation of the presence (+) or absence (-) in the mature bone in the experiment. 
 Autogenous Bone Blood Clot HA/βTCP 
Bone Maturation 
(%) 
Mature Bone 
(100%) 
Immature 
Bone (55%) 
Mature Bone 
(100%) 
Immature 
Bone (9%) 
Mature Bone 
(100%) 
Immature 
Bone (18%) 
Rabbit 1 + - + - + - 
Rabbit 2 + + + + + + 
Rabbit 3 + + + - + + 
Rabbit 4 + - + - + + 
Rabbit 5 + + + - + + 
Rabbit 6 + - + - + + 
Rabbit 7 + - + - + + 
Rabbit 8 + - + - + + 
Rabbit 9 + + + - + - 
Rabbit 10 + + + - + + 
Rabbit 11 + + + - + + 
 
The animals were followed and monitored daily, and no adverse events were observed from 
the postoperative period until the moment of euthanasia. Furthermore, it should be noted that 
animals went back to their normal habits and motor functions shortly after they had recovered from 
the effects of anesthesia; thus, the result was considered positive from a clinical perspective. When 
the surgical sites were accessed to collect the material, there were no tissue infiltrations in the 
regions where bone filling was performed with autogenous bone, in any of the animals. 
Similarly, in regions where fillings were performed with HA/βTCP, no tissue infiltrations 
were found in any of the animals; thus evincing mechanical strength, gradual bone substitution, and 
the biphasic feature of the material. However, regions filled using blood clots revealed tissue 
infiltrations that caused small bone structural defects in all animals (Figure 2). 
Through microscopic analysis it was observed that all HA/βTCP bioceramics blades had 
cells considered feasible for bone neo-formation. Osteoblasts were found in 9 of the 11 HA/βTCP 
bioceramics blades, whereas osteoclasts were observed in 6 blades, both of which showed evidence of 
bone growth and metabolism. Only 1 of the HA/βTCP blades presented a greater number of 
osteoblasts and osteoclasts than those of the others. Furthermore, these cells were not observed in 2 
of the 11 blades, which suggests that each animal had a different response to the same material in the 
same period of time (Figure 3). 
 Pesqui. Bras. Odontopediatria Clín. Integr. 2019; 19:e3364 
 
7 
   
 A 
 
 B 
   
Figure 2. A: Autogenous bone HA/βTCP blood; B: Blood clot. 
 
 
 
Figure 3. A: Presence of mature bone with osteocytes and bone metabolism, in the presence of 
osteoclasts and osteoblasts. B: Presence of increased amount of mature bone and bone in the 
maturation process, with minimal presence of osteoclasts and large numbers of osteoblasts. C: Presence 
of bone with a high metabolism rate and presence of osteoblasts and osteoclasts, in close contact with 
HA/βTCP bioceramics and mature bone with osteocytes. 
 
It was observed that there were a greater number of osteoblasts and osteoclasts in addition 
to a greater presence of immature bone on the autogenous bone blades than that of the the 
HA/βTCP bioceramics blades. This shows an acceleration of the bone maturation process when 
HA/βTCP bioceramics were present (Table 2). 
 
Table 2. Representation of the presence (+) or absence (-) of autogenous bone in the experiment. 
Autogenous Bone Osteoblasts Osteoclasts Mature Bone Immature Bone 
Rabbit 1 ++ + + - 
Rabbit 2 +++ + + + 
Rabbit 3 ++ + + + 
Rabbit 4 + + + - 
Rabbit 5 ++ + + + 
Rabbit 6 + + + - 
Rabbit 7 + ++ + - 
Rabbit 8 + + + - 
Rabbit 9 +++ + + + 
Rabbit 10 +++ + + - 
Rabbit 11 ++ ++ + + 
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However, when compared with that of the blood clot, the presence of osteoblasts and 
osteoclasts was greater in the HA/βTCP bioceramics blades, with a smaller presence of mature bone, 
thus evincing faster bone neoformation in the defects filled in with blood clots, with a clinical loss of 
the filling structure (Table 3). 
 
Table 3. Representation of the presence (+) or absence (-) of blood clot in the control group. 
Blood Clot Osteoblasts Osteoclasts Mature Bone Immature Bone 
Rabbit 1 + + + - 
Rabbit 2 ++ + + + 
Rabbit 3 + + + - 
Rabbit 4 - - - - 
Rabbit 5 + + + - 
Rabbit 6 + + + - 
Rabbit 7 - - + - 
Rabbit 8 + + + - 
Rabbit 9 + - + - 
Rabbit 10 + - + - 
Rabbit 11 - - + - 
 
The presence of mature bone and osteocytes were observed in every HA/βTCP bioceramics 
blade; however, immature bone was observed with great significance only in one blade, which also 
had a greater number of osteoblasts and osteoclasts (Table 4). 
 
Table 4. Representation of the presence (+) or absence (-) of HA/βTCP bioceramics in the experiment. 
Bioceramics of 
HA/βTCP 
Osteoblasts Osteoclasts Mature Bone Immature Bone Residual 
Material 
Rabbit 1  +++ ++ + + + 
Rabbit 2 + + + - - 
Rabbit 3 + + + - - 
Rabbit 4 + - + - - 
Rabbit 5 + + + - + 
Rabbit 6 + + + - + 
Rabbit 7 - - + - + 
Rabbit 8 + - + - + 
Rabbit 9 + - + + + 
Rabbit 10 + + + - + 
Rabbit 11 - - + - - 
 
It was also observed that in all HA/βTCP biomaterial blades, there was a greater presence of 
mature bone when the material was directly in contact with the defect walls. Residual HA/βTCP 
material was observed in 7 of the 11 blades, but at low amounts and always located more towards the 
center of the defect, which showed that growth is centripetal, starting by the walls directly in contact 
with the material gradually towards the center of the defect. The presence of residual material on 
these blades also shows individual factors in relation to absorption and the metabolism time in 
animals also evincing the biphasic feature of the material (Figure 4). 
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Figure 4. RM: Residual material: centripetal growth. 
 
Discussion 
In agreement with previous observations, it was found that bone regeneration was best and 
fastest when there was close contact of the HA/βTCP bioceramics with the neighboring bone, 
because of the direct interface resulting from the integration of the cortical and medullar bone with 
the material [15,16]. 
Evidence was given for the osteoconductive and osteoinduction of the HA/βTCP 
bioceramics material, which facilitates regeneration and guiding new bone trabecular [1,6,17,18]. 
Furthermore, complete filling of the defects, without tissue infiltration, which remained stable during 
bone substitution was clinically evinced in all the HA/βTCP bioceramics blades, taking into 
consideration the delays in the bone formation, observed histologically, because of the individual 
reaction to the material. Furthermore, when the process was accelerated, it also affected degradation 
of both the most and least soluble parts [1,5,8,9,19-23]. 
Another factor that should be considered is that, clinically, when the surgery was performed 
to collect the material for analysis, we noticed that the appearance of the neoformed bone, despite not 
using membranes, was normal and without any tissue infiltration in the region. Thus, we believed 
that it is not necessary to use membranes to achieve good results with the material, as its mechanical 
resistance and biphasic features maintain the desired structural support until bone substitution has 
been completed [24-26]. 
In addition, the material was very effective in filling inlay bone defects; however, further 
studies are needed to show the osteogenic capacity of the material [2,6,16,26]. It was shown that the 
material guided the neoformation of bone trabeculae, and induced neoformation when in contact with 
the bone, and can thus be classified as osteoconductive and osteoinductive [22,26]. 
Clinically, the material appeared to be more resistant to perforation, showing higher 
hardness than that of the other fillings. The difficult decalcification evinced this when preparing the 
histologic blades, in which bone calcification required twice the time during the process [27]. 
However, studies in consecutive years have reported that the bone density of the grafted region 
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when perforated for implant placement did not present clinical differences than that of contiguous 
natural bone sites, requiring more specific analysis for these conclusions [8,12,27]. 
The association between the bioceramics HA/βTCP and other materials has been studied; 
the use of platelet rich plasma (PRP), phosphate silicone, fibrin glue, or even autogenous bone favor 
increased repair speed and improvement in neoformed bone structure [6,9,10,17,18,28,29]. In 
another study, no changes were observed to the morphology and number of viable cells present in 
the site with new bone formation in any of the HA/βTCP bioceramics blades, nor in the blood clot 
and autogenous bone blades [30]. 
Based on the type of material and size of its particles, there is a greater or lesser use of that 
material during bone matrix formation. Hence, it is possible that particle size affects the formation of 
the bone trabeculae, improving or worsening its absorption, since bone deposition occurs 
simultaneously. In the present study, the size of the HA/βTCP bioceramics particles was 100–200 
µm, which facilitated its absorption and liberation of calcium ions, favoring the osteoblast mitosis 
process, promoting osteoinduction [22,25]. 
While conducting this study, we considered the concept of critical defects in the mandible of 
rabbits [17]; however, the size of the defect should be considered since it could need the association 
of HA/βTCP bioceramics with autogenous or other osteogenic materials to promote better and 
faster bone repair in larger defects; thus, making it feasible to create a new cellular bone matrix in 
that region [6,12,26]. Nevertheless, in 2016, the material was considered as ideal for using in long 
bones as a substitute to autogenous bone even if used alone [17]. Another positive factor of the 
material that should be reported its easy application, as it is known that several products are difficult 
to apply, and its form of application and presentation would make it easy to use in daily practice [6]. 
Locally, there was acceleration in the process of bone neoformation in defects filled with HA/βTCP 
bioceramics, compared with those filled with blood clot. However, when compared to autogenous 
bone, bone neoformation was similar [16,22,23,26]. 
 
Conclusion 
The bioceramic HA/βTCP was shown to be a biocompatible bone substitute, with 
osteoinductive and osteoconductive characteristics that accelerated the process of bone neoformation 
relative to autogenous bone and blood clot. Thus, it is effective for the repair of bone defects. 
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